drugset / Trial / NCT01987011
Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers
Phase 3
Completed
420 enrolled
Green Cross Corporation
Korean Center for Disease Control and Prevention · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to evaluate the immunogenicity and safety of the investigational vaccine in the subjects during their participation in the study.
Timeline
- Start
- 2013-08
- Primary completion
- 2013-10
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MG1109 | Vaccine | 0.5 ml | Intramuscular |